| Original language | English |
|---|---|
| Article number | e012102 |
| Journal | Journal of the American Heart Association |
| Volume | 8 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published or Issued - 5 Mar 2019 |
Keywords
- Editorials
- anticoagulation
- atrial fibrillation
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of the American Heart Association, Vol. 8, No. 5, e012102, 05.03.2019.
Research output: Contribution to journal › Editorial › peer-review
TY - JOUR
T1 - Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver
T2 - Are Low-Dose Non-Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
AU - Gallagher, Celine
AU - Sanders, Prash
AU - Wong, Christopher X.
N1 - Funding Information: Ms Gallagher is supported by a Leo J. Mahar Scholarship from the University of Adelaide. Dr Sanders is supported by Practitioner Fellowships from the National Health and Medical Research Council of Australia and the National Heart Foundation of Australia. Dr Wong is supported by a Mid-Career Fellowship from The Hospital Research Foundation and a Post-Doctoral Fellowship from the National Heart Foundation of Australia. Funding Information: Scientific, and CathRx. Dr Sanders reports that the University of Adelaide has received on his behalf lecture and/or consulting fees from Biosense-Webster, Medtronic, St Jude Medical, and Boston Scientific. Dr Sanders reports that the University of Adelaide has received on his behalf research funding from Medtronic, St Jude Medical, Boston Scientific, Biotronik, and LivaNova. Dr Wong reports that the University of Adelaide has received on his behalf research, lecture, and/or travel funding from Novartis, Servier, Boehringer-Ingelheim, and Medtronic. Funding Information: Dr Sanders reports having served on the advisory board of Biosense-Webster, Medtronic, St Jude Medical, Boston Scientific, and CathRx. Dr Sanders reports that the University of Adelaide has received on his behalf lecture and/or consulting fees from Biosense-Webster, Medtronic, St Jude Medical, and Boston Scientific. Dr Sanders reports that the University of Adelaide has received on his behalf research funding from Medtronic, St Jude Medical, Boston Scientific, Biotronik, and LivaNova. Dr Wong reports that the University of Adelaide has received on his behalf research, lecture, and/or travel funding from Novartis, Servier, Boehringer-Ingelheim, and Medtronic. Ms Gallagher is supported by a Leo J. Mahar Scholarship from the University of Adelaide. Dr Sanders is supported by Practitioner Fellowships from the National Health and Medical Research Council of Australia and the National Heart Foundation of Australia. Dr Wong is supported by a Mid-Career Fellowship from The Hospital Research Foundation and a Post-Doctoral Fellowship from the National Heart Foundation of Australia.
PY - 2019/3/5
Y1 - 2019/3/5
KW - Editorials
KW - anticoagulation
KW - atrial fibrillation
UR - http://www.scopus.com/inward/record.url?scp=85062399490&partnerID=8YFLogxK
U2 - 10.1161/JAHA.119.012102
DO - 10.1161/JAHA.119.012102
M3 - Editorial
C2 - 30834801
AN - SCOPUS:85062399490
SN - 2047-9980
VL - 8
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 5
M1 - e012102
ER -